Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates if a report of a patient with a serious side effect is linked to the shot. Read the full report here.
Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates if a report of a patient with a serious side effect is linked to the shot. Read the full report here.